Related Experiment Video

Updated: Aug 16, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Chemokine receptor CCR1: a new target for progressive kidney disease

Volha Ninichuk1, Hans-Joachim Anders

  • 1Nephrological Center, Medical Policlinic, Ludwig Maximilians University of Munich, Germany.

American Journal of Nephrology
|August 10, 2005
PubMed

Insights

Chemokine receptor CCR1 blockade effectively reduces leukocyte infiltration and improves kidney injury in progressive kidney disease models, even in advanced stages. This finding offers new therapeutic targets for chronic kidney disease.

Area of Science:

  • Nephrology
  • Immunology
  • Pharmacology

Background:

  • Leukocyte infiltration exacerbates kidney disease progression.
  • Chemokines mediate leukocyte entry into the kidney, presenting chemokine receptors as therapeutic targets.

Purpose of the Study:

  • To investigate the role of chemokine receptor CCR1 in leukocyte recruitment in kidney disease.
  • To evaluate the therapeutic potential of CCR1 blockade in preclinical kidney disease models.

Main Methods:

  • Utilized mutant mice and specific small molecule antagonists.
  • Assessed leukocyte adhesion, transendothelial diapedesis, and kidney injury in various progressive kidney disease models.

Main Results:

  • CCR1 demonstrated non-redundant functions in leukocyte adhesion and diapedesis.
  • CCR1 blockade significantly improved kidney injury in multiple disease models, irrespective of treatment initiation timing.

Conclusions:

  • Chemokine receptor CCR1 is a critical mediator of leukocyte recruitment in kidney disease.
  • Targeting CCR1 with small molecule antagonists represents a promising therapeutic strategy for chronic kidney disease.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...